Skip to main content
Veterinary Medicines

RISPOVAL RS-BVD LYOPHILISAT ET SOLVANT POUR SUSPENSION INJECTABLE POUR BOVINS

Authorised
  • Water for injection
  • Bovine viral diarrhoea virus, strain RIT 4350, Live
  • Bovine respiratory syncytial virus, strain 375, Live

Product identification

Medicine name:
RISPOVAL RS-BVD LYOPHILISAT ET SOLVANT POUR SUSPENSION INJECTABLE POUR BOVINS
Active substance:
  • Water for injection
  • Bovine viral diarrhoea virus, strain RIT 4350, Live
  • Bovine respiratory syncytial virus, strain 375, Live
Target species:
  • Cattle
Route of administration:
  • Intramuscular use

Product details

Active substance and strength:
  • Water for injection
    2.00
    millilitre(s)
    /
    1.00
    Dose
  • Bovine viral diarrhoea virus, strain RIT 4350, Live
    5.50
    log10 tissue culture infective dose 50
    /
    1.00
    Dose
  • Bovine respiratory syncytial virus, strain 375, Live
    4.00
    log10 tissue culture infective dose 50
    /
    1.00
    Dose
Pharmaceutical form:
  • Lyophilisate and solvent for suspension for injection
Withdrawal period by route of administration:
  • Intramuscular use
    • Cattle
      • Meat and offal
        0
        day
    • Cattle
      • Milk
        0
        day
Anatomical therapeutic chemical veterinary (ATCvet) codes:
  • QI02AD03
Authorisation status:
  • Valid
Authorised in:
  • France
Package description:

Additional information

Entitlement type:
  • Marketing Authorisation
Marketing authorisation holder:
  • Zoetis France
Marketing authorisation date:
Manufacturing sites for batch release:
  • Zoetis Belgium
Responsible authority:
  • ANSES
Authorisation number:
  • FR/V/2675522 5/1988
Date of authorisation status change:

Documents

Summary of Product Characteristics

This document does not exist in this language (English). You can find it in another language below.
French (PDF)
Published on: 30/11/2023

Package Leaflet and Labelling

This document does not exist in this language (English). You can find it in another language below.
French (PDF)
Published on: 27/02/2023
How useful was this page?:
No votes yet
"Please do not include any personal data, such as your name or contact details. If you do, you consent to the processing of that data in accordance with EMA’s Privacy Statement concerning requests for information or access to documents. If you would like a reply from EMA, please Send a question to EMA instead."